The largest database of trusted experimental protocols

12 protocols using tim 3 pe

1

Quantification of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Counting of Th17, Treg, exhausted T, and exhausted Treg cell was performed using flow cytometry. The monoclonal antibodies of surface and intracellular antigens used for counting Th17 cells were CD4-FITC (BioLegend, US, cat. no. 357405) and IL-17A-PE (BioLegend, US, cat. no. 506903), and CD4-FITC (BioLegend, US, cat. no. 357405), CD25-PE (BioLegend, US, cat. no. 985802), and CD127-PerCP-Cy5.5 (BioLegend, US, cat. no. 351321) were used for Treg cells; CD8-FITC (BioLegend, US, cat. no. 980908), PD-1-PerCP-Cy5.5 (BioLegend, US, cat. no. 329913), and Tim-3-PE (BioLegend, US, cat. no. 345006) for exhausted T cells; and CD4-FITC (BioLegend, US, cat. no. 357405), CD25-PE (BioLegend, US, cat. no. 985802), and PD1-PerCP-Cy5.5 (BioLegend, US, cat. no. 329913) for exhausted Treg cells [18 (link)].
+ Open protocol
+ Expand
2

Comprehensive Immunophenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved peripheral blood mononuclear cells were thawed and stained in Horizon Brilliant Stain Buffer (BD) containing all antibodies and Live/Dead Near-IR (Life Technologies) at 1:300 dilution and stained at 4°C for 30 minutes in Horizon. Panel 1 included the following: CD3 BV570 (UCHT1), CCR7 Pacific Blue (G043H7), and CD27 AlexaFluor700 (M-T271) (all BioLegend); CD4 BV605 (RPA-T4) and CD8 BV650 (RPA-T8) (BD); programmed cell death protein 1 (PD-1) phycoerythrin (PE)–eFluor610 (eBioJ105), CD45RA fluorescein isothiocyanate (HI100), and T cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) peridinin-chlorophyll protein complex (PerCP)–eFluor710 (MBSA43) (eBioscience); and Tim-3 PE (344823) (R&D).
Panel 2 included the following: CD3 BV570, CD38 AlexaFluor700 (HB-7) (BioLegend); CD4 BV605, CD8 BV650, PD-1 PE-eFluor610, and Tim-3 PE. After this, cells were washed twice before fixation and permeabilization with Foxp3 Buffer Set (BD). Staining for intracellular epitopes was performed with: T-bet fluorescein isothiocyanate (4B10) (BioLegend) and Eomes eFluor660 (WD1928) (eBioscience). Samples were acquired on an LSR II flow cytometer (BD). Data were analyzed using FlowJo software (version 10.8.0r1; Tree Star).
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of CAR T Cell Phenotype

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of EGFR and other proteins on the tumor cell surface was detected by flow cytometry using the anti-EGFR antibody (BD, San Jose, CA, USA). In brief, the CAR T cells were collected from culture and assayed with monoclonal antibodies against human CD25-PC5 and CD69-PC5 (Beckman Coulter Inc., Indianapolis, IN, USA), CD3-PE-CY5, CD4-PE, CD8-FITC, CD45RO-PE-CY5, CD62L-PE, TIM3-PE, and LAG3-Alexa Fluor 647 (Biolegend, San Diego, CA, USA) and CCR7-FITC, CD107α-PE-CY5, and PD-1-PE (BD, San Jose, CA, USA) according to a previous study40 (link) or the manufacturers’ instructions.
EGFR-modified CAR expression was detected by using an indirect method with biotinylated EGFR protein and streptavidin-coupled PE antibody (BD). Fluorescence was assessed using a Beckman Coulter Gallios™ flow cytometer, and the data were analyzed with the FlowJo vX.0.7 and Kaluza v1.5 software (Beckman Coulter Inc.).
+ Open protocol
+ Expand
4

Comprehensive Immune Phenotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following anti-human antibodies were used for staining: CD3-FITC, CD3- Alexa Fluor 700, CD8a-Alexa Fluor700, CD4-Percp-Cy5.5, CD4-Alexa Fluor 700, CD25-PE, CD25-PE-Cy7, Foxp3-FITC, Foxp3- Percp-Cy5.5, Foxp3-BV421, CD127-APC, CD39-APC, LAP-PE, IL-10-PE, TIM-3-PE, TIM-3-BV421, IFN-γ receptor-PE, IFN-γ- APC, Granzyme B-PE-dazzle E, PD-1-APC, PD-1- PE-Cy7, PD-1- Percp-Cy5.5, CTLA-4-PE, CTLA-4-FITC, ki67-Alexa Fluor 488 and their respective isotype controls were purchased from Biolegend. Recombinant human IFN-γ (R&D Systems) was used at 200 ng/ml. Anti-PD-1 Ab (Nivolumab from Bristol-Myers Squibb), anti-Tim-3 (clone 2E2 from Biolegend) and isotype were used at 10µg/ml.
+ Open protocol
+ Expand
5

Profiling Exhausted CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotypic markers expressed by CD4+ T cells isolated at day 0 and from day 14 were analysed by flow cytometry. Cells were fixed using Human FoxP3 Buffer Set (BD Biosciences, 560098), and stained with anti-human: CD4 BV510, LAG-3 Pe/Cy7, TIM-3 PE, TIGIT PeDazzle594, CTLA-4 BV421 (all BioLegend, 317444, 369310, 345006, 372716, 369606), CD3 FITC, and PD-1 APC (both ThermoFisher, 11-00390-42, 17-2799-42 respectively). Cells were then analysed using a cyAn ADP flow cytometer (Beckman Coulter).
+ Open protocol
+ Expand
6

Phenotypic Analysis of Engineered Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The studied cells were freshly stained with anti-MUC1 antibody (EP1024Y) diluted to 1:50 in 2% FBS in PBS. Antibodies that were used to investigate the cell phenotypes including anti-CD3-FITC, CD4-APC, CD8-APC, CD19-APC, CD16-APC, CD69-APC, and CD62L-APC were purchased from ImmunoTools GmbH (Friesoythe, Germany), anti-CD45RA-PE-cyanine7 and PD-1-PE from Invitrogen (Carlsbad, USA), anti-CD56-PE, LAG-3-PE and TIM-3-PE from BioLegend (San Diego, USA), and anti-CD25-PerCP-cyanine5.5 from eBioscience, Inc. (California, USA).
To detect the CARs expression on transduced lymphocytes, the transduced cells were harvested, blocked with 1% BSA, and stained with biotin-conjugated protein-L (Thermo Fisher Scientific, Waltham, MA, USA). Alexa Fluor 488 dye-conjugated streptavidin was finally added. The data were acquired on a BD FACSVerse or BD Accuri C6 flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and analyzed with FlowJo software version 10.
+ Open protocol
+ Expand
7

HIV-1 Infection Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs (1 x 106/ml) were infected with 100 TCID50 of various HIV-1 strains (92UG037: primary R5-tropic strain; YU2B and BaL: R5-tropic lab strains, 93BR020: dual-tropic primary isolate; NL4-3: X4-tropic lab strain) and simultaneously treated with a range of concentrations of IND02-trimer in 24-well plates (Greiner) in duplicates. Cells were washed, fixed (4% paraformaldehyde) and stained on several days post infection (1-4-9-13-19) using the following mAbs against PD-1-Brilliant Violet 421, CD3-FITC, Tim-3-PE, CD4-PE-Cy7 (all from Biolegend) and CD8-APC (Miltenyi). Multicolor flow cytometric analyses were performed on a FACS Verse (BD Biosciences).
+ Open protocol
+ Expand
8

Isolation and Analysis of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to isolate peripheral blood mononuclear cells (PBMCs) from each sample, 1 mL of heparinized whole blood from CHB patients or healthy controls was collected and subjected to Ficoll-Hypaque density gradient centrifugation. After centrifugation, PBMCs were collected and washed with FACS buffer (phosphate-buffered saline [PBS] containing 0.5% BSA, BD Biosciences). For T-cell staining, the collected PBMCs were stained with the following fluorochrome-conjugated anti-human antibodies: CD3-APC, CD8-FITC, PD-1-PE, Tim-3-PE, CD3-APC, CD4-PerCP and CD25-FITC (Biolegend, San Diego, CA, USA) for 30 min. The stained cells were then washed with FACS buffer (BD Biosciences) and resuspended in a Fixation/Permeabilization Solution (BD Biosciences), prior to being washed and resuspended with PBS, and acquired on a FACSCalibur flow cytometer (BD Biosciences). After gating, the proportions of CD3+CD8+PD-1+, CD3+CD8+Tim-3+ and CD3+CD4+CD25high cells were determined. The data were analyzed using FlowJo software (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand
9

Multiparameter Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of surface markers was determined using specific antibodies; CD14-FITC, CD11c-APC/CD11c-V450, CD123-PE, HLA-DR-APC-Cy7/PerCP, CD69-FITC, CD25-PE, CCR7-PE-Cy7, CD27-PE, PD-1-PE (all from BD Biosciences, San Jose, CA), CD3-V450 (Pharmingen), CD45RO-ECD (Beckman Coulter, Indianapolis, IN, USA), Tim3-PE, TcR Vβ-17-PE, TcR Vβ-3-PE-Cy7 and TCR Vβ-13.1-PE (all from Biolegend).
Cells were stained in a total volume of 100ul with a previously titrated volume of antibody for 25–30 min, on ice (4°C). Cells were then washed and fixed with 100ul of 1% formaldehyde. Samples were analysed by flow cytometry (FCM) on a FACSCalibur or LSR-II (BD Biosciences), and data analyzed using Weasel (Version 2.7; WEHI, Melbourne, Australia).
+ Open protocol
+ Expand
10

Comprehensive Immune Profiling of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR T cells (2×105 cells per test) were labeled with antibodies at 4°C for 15 min. Flow cytometry was performed using a MACSQuant Analyser 10 Flow Cytometer (Miltenyi Biotec, Bergisch Gladbach, Germany), and data were analyzed by FlowJo V.10.7.1 software (FlowJo). Cells were subjected to SSc-FSc and gated as the CD3+ T-cell population. For transfection efficiency: CD19 CAR detection reagent, anti-biotin PE, and CD3-APC (Miltenyi Biotec, Bergisch Gladbach, Germany); T-cell phenotype: CD3-PerCP (UCHT1), CD8-PE (SK1), (BD Bioscience, New Jersey, USA), CD4-APC (BioLegend, San Diego, California, USA); memory phenotype: CD3-PerCP (UCHT1), CD45RO-VioGreen (UCHL1), and CD62L-VioBlue (DREG-56) (BD Bioscience, New Jersey, USA); exhaustion: CD3-PerCP, PD1(CD279)-APC, TIM-3-PE, LAG3-PE, and TIGIT-APC (BioLegend, San Diego, California, USA); activation: CD3-PerCP, CD25-PE, and CD69-APC (BioLegend, San Diego, California, USA); and for cytolytic activity: CD3-PE (OKT3), CD19-APC (HIB19) (BioLegend, San Diego, California, USA), and 7AAD-PerCP (BD Bioscience, New Jersey, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!